Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma

BACKGROUND: New biomarkers are needed for the prognosis of advanced colorectal cancer, which remains incurable by conventional treatments. O(6)-methylguanine DNA methyltransferase (MGMT) methylation and protein expression have been related to colorectal cancer treatment failure and tumor progression...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Oliver, Jaime Antonio, Ortiz, Raúl, Melguizo, Consolación, Álvarez, Pablo Juan, Gómez-Millán, Jaime, Prados, Jose
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4227111/
https://ncbi.nlm.nih.gov/pubmed/25015560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-511
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars